Inactive Instrument
DIAL BIORFD Stock Nasdaq Stockholm
Stocks
DIABIO BTA
SE0019173832
Biotechnology & Medical Research
| 1 day | +2.99% |
| Manager | Title | Age | Since |
|---|---|---|---|
Karin Wehlin
CEO | Chief Executive Officer | - | 2023-11-22 |
Fata Mrsic
DFI | Director of Finance/CFO | - | 2024-06-13 |
Emelie Danefur
CTO | Chief Tech/Sci/R&D Officer | - | 2023-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 41 | 2020-12-31 | |
| Chairman | 70 | 2020-12-31 | |
Kushagr Punyani
BRD | Director/Board Member | 35 | 2019-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.99% | +15.00% | - | - | 705K | |
| +0.03% | -5.67% | +50.74% | +76.76% | 70.61B | |
| +0.66% | -9.75% | +6.97% | +52.62% | 51.01B | |
| +0.31% | -0.14% | +8.84% | +32.99% | 48.1B | |
| +0.90% | -1.46% | +32.32% | +32.69% | 42.78B | |
| +2.21% | -6.61% | +302.05% | +701.45% | 40.67B | |
| -1.15% | -3.11% | +9.47% | +98.83% | 40.3B | |
| +0.45% | -1.20% | +9.11% | +43.54% | 30.59B | |
| -4.56% | -13.30% | +39.21% | +2.24% | 28.16B | |
| -1.16% | -1.84% | -6.09% | -11.99% | 24.36B | |
| Average | +0.06% | -2.81% | +50.29% | +114.35% | 41.84B | |
| Weighted average by Cap. | -0.03% | -2.97% | +52.17% | +118.72% |
Employees
4
